文献速递头颈部肿瘤放疗

局部晚期咽癌与喉癌放疗后失败模式及动态的真实世界分析

Defining failure patterns and dynamics in locally advanced pharyngeal and laryngeal SCC following radiotherapy: Real-World Insights in the modern Era!
PubMed 文献 · Clin Transl Radiat Oncol · 2025-08-07

本研究回顾2016至2023年177例接受根治性调强或容积旋转调强放疗的局部晚期口咽、下咽及喉鳞癌患者,分析局部区域复发模式与预后因素。28.2%患者出现局部区域复发,多数在放疗后第一年内且多见于HPV阴性者,失败主要位于高剂量靶区内。HPV状态、远处转移和化疗与预后及复发显著相关。

要点

  • 177例中28.2%出现局部区域复发,多数在放疗后第一年内。
  • 复发主要位于高剂量靶区内(A型65%、C型14%),边缘及野外复发不可忽视。
  • HPV阳性者局部区域复发率低于HPV阴性者(16.0% vs 34.4%)。

核心结论

  • 局部区域复发仍是局部晚期咽癌与喉癌放疗后的主要挑战,尤其在HPV阴性患者中。
  • 多数失败位于中心高剂量区,但边缘及野外复发提示需改进靶区勾画和自适应放疗策略。

研究设计与样本

  • 单中心回顾性研究,2016至2023年共审查213例,177例符合纳入标准。
  • 患者为局部晚期口咽、下咽及喉鳞癌,接受根治性调强或容积旋转调强放疗,联合或不联合全身治疗。
  • 局部区域复发定义为原发肿瘤区域或区域淋巴结复发,失败模式按复发模型分为A至E型。

主要发现

  • 50/177(28.2%)患者出现局部区域复发,共81个复发病灶。
  • 多数复发发生在放疗后第一年内(39/177,22.0%),以HPV阴性患者为主。
  • 失败主要位于高剂量靶区内(A型65%,C型14%),边缘复发(B和D型)占22%,E型占5%。
  • HPV阳性患者局部区域复发少于HPV阴性患者(16.0% vs 34.4%)。
  • 多因素分析显示HPV状态是OS、PFS和LRR的显著预后因素;远处转移对OS、PFS和LRR有负面影响;LRR对OS有更差趋势(p=0.072);化疗对PFS和LRR有显著影响。

临床怎么用

  • 对HPV阴性局部晚期咽癌与喉癌患者应加强治疗后随访,尤其关注第一年内的复发风险。
  • 靶区勾画和自适应放疗策略的改进可能有助于减少边缘及野外复发。
  • HPV状态、远处转移和化疗使用可作为预后分层与治疗决策的参考因素。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: We aimed to evaluate the prevalence and patterns of locoregional recurrence (LRR), outcome and prognostic factors in patients with locally advanced squamous cell carcinoma of the oropharynx, hypopharynx, and larynx treated with intensity-modulated or volume-modulated arc therapy definitive radiotherapy (RT) with or without systemic therapy. METHODS: Of the 213 reviewed patients treated between 2016 and 2023, 177 met the inclusion criteria. LRR was defined as recurrence in the primary tumor region or regional nodes. Failure patterns were classified based on a recurrence model, including central high-dose (A), peripheral high-dose (B), central elective(C), peripheral elective (D), and out-of-field recurrence (E). RESULTS: LRR was observed in 50/177 (28.2%) patients and 81 recurrent lesions. Most recurrences occurred within the first year after RT (39/177, 22.0%), predominantly in HPV-negative patients. The majority of failures were within the high-dose target volume (65% type A, 14% type C), with marginal recurrences (types B and D) occurring in 22% of cases and type E in 5% of patients. HPV-positive patients had fewer LRR (16.0% vs. 34.4% in HPV-negative patients).Multivariate analysis identified HPV status as a significant prognostic factor for OS, PFS and LRR. The occurrence of distant metastases showed a negative impact on OS, PFS and LRR. LRR showed a trend toward worse OS (p = 0.072). Chemotherapy had a significant effect on PFS and LRR. CONCLUSION: LRR remains a challenge, especially in HPV-negative patients. Most failures occurred centrally, but marginal and extra-field recurrences highlight the need for improved target delineation and adaptive RT strategies. Further research is needed to optimize treatment in high-risk patients.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Agolli L, Reinhard L, Langer C, et al. Defining failure patterns and dynamics in locally advanced pharyngeal and laryngeal SCC following radiotherapy: Real-World Insights in the modern Era! Clin Transl Radiat Oncol. 2025. PMID: 40821397. doi:10.1016/j.ctro.2025.101026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。